GrimAgeAA

1. GrimAgeAA predicts polypharmacy in humans.

   “remained a significant predictor of walking speed, .polypharmacy, frailty, and mortality in fully adjusted models.”

   Humansfully adjusted modelsup to 10-year follow-upn = 490

   GrimAge Outperforms Other Epigenetic Clocks in the Prediction of Age-Related Clinical Phenotypes and All-Cause Mortality

   The journals of gerontology. Series A, Biological sciences and medical sciences·30 Apr 2021

More on Polypharmacy

1. GrimAgeAA predicts walking speed in humans.

   “remained a significant predictor of walking speed, .polypharmacy, frailty, and mortality in fully adjusted models.”

   Humansfully adjusted modelsup to 10-year follow-upn = 490

   GrimAge Outperforms Other Epigenetic Clocks in the Prediction of Age-Related Clinical Phenotypes and All-Cause Mortality

   The journals of gerontology. Series A, Biological sciences and medical sciences·30 Apr 2021

More on Walking speed

1. GrimAgeAA predicts frailty in humans.

   “remained a significant predictor of walking speed, .polypharmacy, frailty, and mortality in fully adjusted models.”

   Humansfully adjusted modelsup to 10-year follow-upn = 490

   GrimAge Outperforms Other Epigenetic Clocks in the Prediction of Age-Related Clinical Phenotypes and All-Cause Mortality

   The journals of gerontology. Series A, Biological sciences and medical sciences·30 Apr 2021

1. GrimAgeAA predicts mortality in humans.

   “remained a significant predictor of walking speed, .polypharmacy, frailty, and mortality in fully adjusted models.”

   Humansfully adjusted modelsup to 10-year follow-upn = 490

   GrimAge Outperforms Other Epigenetic Clocks in the Prediction of Age-Related Clinical Phenotypes and All-Cause Mortality

   The journals of gerontology. Series A, Biological sciences and medical sciences·30 Apr 2021